Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
Jan Philipp Bewersdorf, Kishan Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington, Amer M. Zeidan
Topics & Concepts
DaunorubicinCytarabineMyeloid leukemiaMedicineLeukemiaInternal medicineOncologyPharmacologyAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research